Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet–Induced Obesity
Open Access
- 3 August 2010
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 59 (10), 2495-2504
- https://doi.org/10.2337/db09-1554
Abstract
OBJECTIVE: Given the pleiotropic effect of eicosapentaenoic acid (EPA), it is interesting to know whether EPA is capable of improving obesity. Here we examined the anti-obesity effect of EPA in mice with two distinct models of obesity. RESEARCH DESIGN AND METHODS: Male C57BL/6J mice were fed a high-fat/high-sucrose diet (25.0% [w/w] fat, 32.5% [w/w] sucrose) (HF/HS group) or a high-fat diet (38.1% [w/w] fat, 8.5% [w/w] sucrose) (HF group) for 4–20 weeks. A total of 5% EPA was administered by partially substituting EPA for fat in the HF/HS + EPA and HF + EPA groups. RESULTS: Both the HF/HS and HF groups similarly developed obesity. EPA treatment strongly suppresses body weight gain and obesity-related hyperglycemia and hyperinsulinemia in HF/HS-fed mice (HF/HS + EPA group), where hepatic triglyceride content and lipogenic enzymes are increased. There is no appreciable effect of EPA on body weight in HF-fed mice (HF + EPA group) without enhanced expression of hepatic lipogenic enzymes. Moreover, EPA is capable of reducing hepatic triglyceride secretion and changing VLDL fatty acid composition in the HF/HS group. By indirect calorimetry analysis, we also found that EPA is capable of increasing energy consumption in the HF/HS + EPA group. CONCLUSIONS: This study is the first demonstration that the anti-obesity effect of EPA in HF/HS-induced obesity is associated with the suppression of hepatic lipogenesis and steatosis. Because the metabolic syndrome is often associated with hepatic lipogenesis and steatosis, the data suggest that EPA is suited for treatment of the metabolic syndrome.Keywords
This publication has 48 references indexed in Scilit:
- Hepatic Stearoyl-CoA Desaturase-1 Deficiency Protects Mice from Carbohydrate-Induced Adiposity and Hepatic SteatosisCell Metabolism, 2007
- Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese SubjectsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Enhancing hepatic glycolysis reduces obesity: Differential effects on lipogenesis depend on site of glycolytic modulationCell Metabolism, 2005
- Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particlesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Molecular mechanisms associated with leptin resistance: n-3 polyunsaturated fatty acids induce alterations in the tight junction of the brainCell Metabolism, 2005
- Regulation of adipocyte differentiation and function by polyunsaturated fatty acidsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppressionJournal of Hepatology, 2003
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002
- Acyl-CoA oxidase of rat liver: A new enzyme for fatty acid oxidationBiochemical and Biophysical Research Communications, 1978